Published in J Clin Oncol on March 01, 1999
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
The argument against sentinel node biopsy for malignant melanoma. BMJ (2000) 3.56
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol (2008) 1.67
Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg (2013) 1.50
Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging (2014) 1.49
Label-free Detection of Lymph Node Metastases with US-guided Functional Photoacoustic Imaging. Radiology (2015) 1.48
Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg (2005) 1.47
Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making. Am J Surg (2008) 1.39
Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A (2009) 1.38
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol (2006) 1.24
Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. J Nucl Med (2012) 1.23
Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging (2003) 1.20
Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg (2002) 1.15
Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. Int J Clin Oncol (2009) 1.15
Predictors of sentinel lymph node metastasis in melanoma. Can J Surg (2010) 1.11
Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle. Nat Commun (2014) 1.09
Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma. Ann Surg Oncol (2008) 1.05
A multimarker prognostic assay for primary cutaneous melanoma. Clin Cancer Res (2009) 1.01
SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery? Eur J Nucl Med Mol Imaging (2009) 1.00
Anal melanoma. Clin Colon Rectal Surg (2006) 1.00
Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99
Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol (2011) 0.99
The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg (2007) 0.98
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. J Clin Pathol (2005) 0.98
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol (2011) 0.97
Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period. Cancer Imaging (2006) 0.96
Histopathological patterns of melanoma metastases in sentinel lymph nodes. J Clin Pathol (2004) 0.95
Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden. Ann Surg Oncol (2010) 0.95
Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. Cancer Res (2014) 0.94
Treatment of melanoma. Dtsch Arztebl Int (2008) 0.93
Surgical management of melanoma: an EORTC Melanoma Group survey. Ecancermedicalscience (2013) 0.93
The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch (2008) 0.91
Predictors of occult nodal metastasis in patients with thin melanoma. Arch Surg (2010) 0.90
Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging (2003) 0.89
Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg (2011) 0.89
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol (2012) 0.87
Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2004) 0.87
Recent developments in plastic surgery. BMJ (2002) 0.87
Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg (2002) 0.87
Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87
Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature. Radiol Res Pract (2011) 0.87
Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int (2013) 0.85
Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells. Am J Pathol (2005) 0.85
Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ (2006) 0.84
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer (2009) 0.84
Postoperative Complications following Nodal Dissection and Their Association with Melanoma Recurrence. ISRN Surg (2013) 0.84
Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging (2005) 0.84
Sentinel node detection in head and neck malignancies: innovations in radioguided surgery. J Oncol (2009) 0.84
False-negative sentinel node biopsy. Ann Surg Oncol (2009) 0.83
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging (2015) 0.83
Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis (2008) 0.83
Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer (2001) 0.83
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev (2013) 0.82
Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol (2011) 0.82
Clinical utilities and biological characteristics of melanoma sentinel lymph nodes. World J Clin Oncol (2016) 0.82
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma. Melanoma Res (2012) 0.82
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Contrast-enhanced MR imaging of lymph nodes in cancer patients. Korean J Radiol (2010) 0.81
Melanoma biomarkers: Vox clamantis in deserto (Review). Oncol Lett (2010) 0.81
Treatment strategy for cutaneous malignant melanoma. Int J Clin Oncol (2005) 0.80
Clinical significance of skip metastasis in patients with gastric cancer. Gastric Cancer (2007) 0.80
Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma. PLoS One (2011) 0.80
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease. Cancer (2008) 0.80
Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009). BMC Dermatol (2012) 0.80
Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Br J Cancer (2005) 0.79
Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands. Int J Clin Oncol (2012) 0.79
Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland. Ann Surg Oncol (2006) 0.78
Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized care. Ann Surg Innov Res (2014) 0.78
Bilateral breast metastasis as the first sign of recurrence of a cutaneous melanoma: A case report. Ulus Cerrahi Derg (2013) 0.78
Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol (2003) 0.77
Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database. JAMA Otolaryngol Head Neck Surg (2014) 0.77
Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor? World J Surg (2009) 0.77
SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study. J Exp Clin Cancer Res (2013) 0.76
State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am (2014) 0.76
Prediction of sentinel node status and clinical outcome in a melanoma centre. J Skin Cancer (2013) 0.76
Anorectal melanoma metastatic to the breast: a case report and review of the literature. Onco Targets Ther (2016) 0.75
The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique. World J Surg Oncol (2015) 0.75
Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma. J Surg Oncol (2012) 0.75
Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel) (2014) 0.75
A Case of Severe Anaphylactic Reaction Secondary to Isosulfan Blue Dye Injection. Ochsner J (2015) 0.75
Sentinel node studies in truncal melanoma: does an increased number of draining basins correlate with an increased risk of lymph metastasis? Cancer Imaging (2012) 0.75
Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence? Int Ophthalmol Clin (2015) 0.75
Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye. Ann Surg (2016) 0.75
Design and implementation of a prototype head and neck phantom for the performance evaluation of gamma imaging systems. EJNMMI Phys (2017) 0.75
The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging (2011) 0.75
Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma. J Am Coll Surg (2017) 0.75
Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up. Eur J Nucl Med Mol Imaging (2011) 0.75
Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population. Int J Clin Oncol (2007) 0.75
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol (1981) 8.17
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
College binge drinking in the 1990s: a continuing problem. Results of the Harvard School of Public Health 1999 College Alcohol Study. J Am Coll Health (2000) 7.87
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol (1999) 7.59
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell (1997) 6.10
US college students' use of tobacco products: results of a national survey. JAMA (2000) 4.87
Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development (2000) 4.71
Phylogenetic footprinting of transcription factor binding sites in proteobacterial genomes. Nucleic Acids Res (2001) 4.29
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol (1994) 3.94
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2001) 3.76
Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell (1990) 3.70
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Retracted Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet (2005) 3.13
The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med (1992) 3.13
Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst (1997) 3.03
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev (1999) 2.86
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol (2004) 2.83
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol (2001) 2.82
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.74
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol (1982) 2.63
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res (1995) 2.56
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med (1996) 2.51
NeuroD regulates multiple functions in the developing neural retina in rodent. Development (1999) 2.49
Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol (2002) 2.42
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst (2000) 2.39
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med (1982) 2.35
A new probe for the diagnosis of myotonic muscular dystrophy. Science (1987) 2.35
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg (1995) 2.25
The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature (1995) 2.24
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. Development (2001) 2.20
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med (2000) 2.19
Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst (2001) 2.18
The triphosphoinositide phosphomonoesterase of brain tissue. Biochem J (1964) 2.16
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med (1993) 2.10
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol (2006) 2.04
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell (1996) 2.04
The triphosphoinositide phosphodiesterase of brain tissue. Biochem J (1964) 2.04
Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. J Immunol (1985) 2.03
Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med (1992) 2.03
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg (1997) 2.00
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med (1988) 1.98
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol (2000) 1.93
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol (1998) 1.92
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol (1999) 1.92
The hydrolysis of triphosphoinositide by extracts of ox brain. Biochem J (1964) 1.89
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88
Cancer chemoprevention: progress and promise. J Natl Cancer Inst (1998) 1.87
CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol (1994) 1.87
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87
A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol (2001) 1.85
Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice. Endocrinology (2012) 1.81
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst (1998) 1.81
Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst (1997) 1.79
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst (1998) 1.78
Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res (1994) 1.78
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am (1998) 1.77
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med (1995) 1.76
Adrenal cortical carcinoma. World J Surg (2001) 1.74
Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics (1995) 1.72
Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol (1992) 1.72
Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol (2000) 1.71